KWMG LLC’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.82M | Buy |
241,593
+7,939
| +3% | +$208K | 0.42% | 74 |
|
|
2026
Q1 | $6.56M | Buy |
233,654
+9,051
| +4% | +$241K | 0.55% | 69 |
|
|
2025
Q4 | $5.59M | Buy |
224,603
+12,295
| +6% | +$310K | 0.48% | 74 |
|
|
2025
Q3 | $5.41M | Buy |
212,308
+14,278
| +7% | +$352K | 0.47% | 77 |
|
|
2025
Q2 | $4.8M | Buy |
198,030
+16,939
| +9% | +$395K | 0.45% | 77 |
|
|
2025
Q1 | $4.59M | Buy |
181,091
+7,938
| +5% | +$208K | 0.47% | 76 |
|
|
2024
Q4 | $4.59M | Buy |
173,153
+10,344
| +6% | +$281K | 0.47% | 81 |
|
|
2024
Q3 | $4.71M | Buy |
162,809
+4,392
| +3% | +$128K | 0.47% | 77 |
|
|
2024
Q2 | $4.43M | Buy |
158,417
+24,285
| +18% | +$669K | 0.48% | 81 |
|
|
2024
Q1 | $3.72M | Buy |
134,132
+8,912
| +7% | +$247K | 0.41% | 88 |
|
|
2023
Q4 | $3.61M | Buy |
125,220
+10,753
| +9% | +$325K | 0.42% | 88 |
|
|
2023
Q3 | $3.8M | Buy |
114,467
+6,887
| +6% | +$244K | 0.48% | 78 |
|
|
2023
Q2 | $3.95M | Buy |
107,580
+8,787
| +9% | +$342K | 0.49% | 77 |
|
|
2023
Q1 | $4.03M | Buy |
98,793
+3,661
| +4% | +$158K | 0.54% | 70 |
|
|
2022
Q4 | $4.87M | Buy |
95,132
+1,359
| +1% | +$65.2K | 0.69% | 45 |
|
|
2022
Q3 | $4.1M | Buy |
93,773
+2,880
| +3% | +$140K | 0.63% | 50 |
|
|
2022
Q2 | $4.77M | Buy |
90,893
+2,814
| +3% | +$143K | 0.72% | 38 |
|
|
2022
Q1 | $4.56M | Buy |
88,079
+310
| +0.4% | +$16.1K | 0.63% | 51 |
|
|
2021
Q4 | $5.18M | Buy |
87,769
+532
| +0.6% | +$26.4K | 0.7% | 43 |
|
|
2021
Q3 | $3.75M | Buy |
87,237
+2,825
| +3% | +$125K | 0.55% | 68 |
|
|
2021
Q2 | $3.31M | Buy |
84,412
+2,268
| +3% | +$88.2K | 0.5% | 76 |
|
|
2021
Q1 | $2.98M | Buy |
82,144
+3,696
| +5% | +$131K | 0.47% | 81 |
|
|
2020
Q4 | $2.89M | Sell |
78,448
-2,298
| -3% | -$84.3K | 0.52% | 71 |
|
|
2020
Q3 | $2.81M | Buy |
80,746
+2,485
| +3% | +$87.1K | 0.57% | 59 |
|
|
2020
Q2 | $2.43M | Buy |
78,261
+8,012
| +11% | +$272K | 0.53% | 64 |
|
|
2020
Q1 | $2.17M | Sell |
70,249
-880
| -1% | -$30K | 0.58% | 54 |
|
|
2019
Q4 | $2.64M | Buy |
71,129
+1,877
| +3% | +$66.9K | 0.58% | 55 |
|
|
2019
Q3 | $2.36M | Buy |
69,252
+2,405
| +4% | +$87.5K | 0.57% | 55 |
|
|
2019
Q2 | $2.75M | Buy |
66,847
+2,344
| +4% | +$93.1K | 0.66% | 38 |
|
|
2019
Q1 | $2.6M | Buy |
64,503
+1,285
| +2% | +$51.5K | 0.64% | 37 |
|
|
2018
Q4 | $2.62M | Buy |
63,218
+1,860
| +3% | +$77.2K | 0.72% | 28 |
|
|
2018
Q3 | $2.56M | Sell |
61,358
-1,003
| -2% | -$38.6K | 0.66% | 34 |
|
|
2018
Q2 | $2.15M | Buy |
62,361
+3,126
| +5% | +$107K | 0.59% | 48 |
|
|
2018
Q1 | $2M | Buy |
59,235
+3,550
| +6% | +$122K | 0.59% | 53 |
|
|
2017
Q4 | $1.91M | Buy |
55,685
+2,955
| +6% | +$101K | 0.58% | 56 |
|
|
2017
Q3 | $1.79M | Buy |
52,730
+3,019
| +6% | +$97K | 0.59% | 49 |
|
|
2017
Q2 | $1.58M | Buy |
49,711
+4,629
| +10% | +$146K | 0.56% | 59 |
|
|
2017
Q1 | $1.46M | Buy |
45,082
+8,004
| +22% | +$252K | 0.56% | 65 |
|
|
2016
Q4 | $1.14M | Buy |
37,078
+3,668
| +11% | +$112K | 0.5% | 67 |
|
|
2016
Q3 | $1.07M | Buy |
33,410
+2,802
| +9% | +$93.7K | 0.52% | 52 |
|
|
2016
Q2 | $1.02M | Buy |
30,608
+1,645
| +6% | +$52.5K | 0.55% | 48 |
|
|
2016
Q1 | $814K | Buy |
28,963
+3,556
| +14% | +$102K | 0.48% | 66 |
|
|
2015
Q4 | $778K | Buy |
25,407
+3,336
| +15% | +$105K | 0.53% | 59 |
|
|
2015
Q3 | $658K | Buy |
22,071
+984
| +5% | +$31.6K | 0.5% | 59 |
|
|
2015
Q2 | $671K | Buy |
21,087
+2,845
| +16% | +$92.7K | 0.49% | 54 |
|
|
2015
Q1 | $589K | Buy |
+18,242
| New | +$580K | 0.47% | 55 |
|
Other funds holding PFE
KWMG LLC's PFE Position: Q2 2026 in Review
KWMG LLC increased its Pfizer (PFE) stake by 3.4% in Q2 2026, buying an estimated $208K and bringing the position to 241,593 shares worth $5.82M. The position accounts for 0.42% of the portfolio, ranked #74.
KWMG LLC first reported a position in PFE in Q1 2015 and has held it in 46 quarters since. The position peaked at $6.56M in Q1 2026. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- KWMG LLC held 241,593 shares of Pfizer worth $5.82M as of Q2 2026.
- KWMG LLC bought 7,939 Pfizer shares in Q2 2026, an estimated $208K.
- Pfizer made up 0.42% of KWMG LLC's portfolio in Q2 2026, its #74 holding.
- KWMG LLC first reported a position in Pfizer in Q1 2015 and has held it in 46 quarters since.
- KWMG LLC's Pfizer position peaked at $6.56M in Q1 2026.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on KWMG LLC's 13F filing for Q2 2026, filed 8 Jul 2026.